Jieli Shu (杰力纾)杰力纾
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司
主要成分Active Ingredients
- 长春西汀Changchun Xiting
药物知识说明
长春西汀是一种在国家药监局注册认定的药品。标注生产企业为沈阳志鹰药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司、沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司、沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 杰力纾) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 沈阳志鹰药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司, 沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司, 沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 杰力纾Recorded Chinese name: 杰力纾
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:长春西汀10mg与氯化钠0.9g。Recorded Chinese description: 100ml:长春西汀10mg与氯化钠0.9g。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 沈阳志鹰药业有限公司Chinese legal name: 沈阳志鹰药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030075
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030075
Manufacturer
Chinese legal name: 沈阳志鹰药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030075
生产企业
沈阳志鹰药业有限公司(国产)
适应症
本品用于改善脑梗塞后遗症、脑出血后遗症、脑动脉硬化症等诱发的各种症状。
用法用量
静脉滴注。开始剂量每天20mg，以后根据病情可增至30mg。每日剂量可分一次或两次静脉缓慢滴注。
不良反应
1.过敏症：有时可出现皮疹，偶有荨麻疹、瘙痒等过敏症状，若出现此症状应停药。|2.精神神经系统：有时头痛、头重、眩晕，偶尔出现困倦感，侧肢的麻木感，脱力感加重。|3.消化道：有时恶心、呕吐，也偶尔出现食欲不振、腹痛、腹泻等症状。|4.循环器官：有时可出现颜面潮红、头昏等症状。|5.血液：有时可出现白细胞减少。|6.肝脏：有时可出现S-GOT，S-GPT，r-GTP升高，偶尔也出现AL-P升高等。|7.肾脏：偶尔可出现血尿素氮升高。
禁忌
1.对本品过敏者禁用。|2.颅内出血急性期禁用。|3.严重缺血性心脏病.严重心律失常者禁用。
注意事项
1.本品应在医生指导下使用。|2.肝肾功能减退者应酌情减量。
贮藏
遮光，密封、在阴凉干燥处保存(10-20℃)。
规格
100ml:长春西汀10mg与氯化钠0.9g。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.